InvestorsHub Logo
Followers 64
Posts 5557
Boards Moderated 0
Alias Born 01/17/2005

Re: jshaffer85 post# 864

Thursday, 10/11/2007 9:51:23 AM

Thursday, October 11, 2007 9:51:23 AM

Post# of 9809
<"Why is the time to treatment failure a better measure of efficacy than total treatment failures over the 50 day period?">


It is like a Survival trial, say the Provenge 36-month analysis.

The total treatment failures measures only how many failed, which is of course the most important thing. Statistically it is a simple analysis (I can give you a link if you want to try).

The time to treatment failure of course also measures how many failed therapy, but spices it up by factoring in a bias for how long exactly each patient lasted on therapy before failing. That is not a simple analysis (usually thing is to do a "Kaplan-Meier" study on the data).

Maybe the most important thing though is that the pre-specified method was the time to treatment failure.

Which is why you and I were able to buy the stock so incredibly cheap.

"....on the biotech battle-field, you need some élan...."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNGX News